$GPRO -15.59% — what the base rate says
$MOBX carries a $17M market cap and a 38.69% midday rip on an F-16 component press release.
Read more →Pattern breakdowns, backtest base rates, and market reads — written off the same historical data the FILTRIX engine screens every day.
$MOBX carries a $17M market cap and a 38.69% midday rip on an F-16 component press release.
Read more →Arbe Robotics ($ARBE) is ripping 28.3% pre-market after announcing selection by a global automotive group for Level 3 autonomous programs across multiple b
Read more →Overtrading is the highest-margin product Wall Street sells.
Read more →Ionis Pharmaceuticals ($IONS) received full FDA approval for its rare brain disorder drug Zanvastro on Friday, and the market rewarded shareholders with a
Read more →Morgan Stanley and Goldman Sachs aren't fighting over Anthropic IPO lead roles out of conviction; underwriters collect their cut on day one whether the deb
Read more →Ionis Pharmaceuticals ($IONS) announced FDA approval for Zanvastro on Friday, and the tape promptly delivered a 10.05% drop.
Read more →Ionis Pharmaceuticals ($IONS) delivered exactly what retail dreams about: official FDA approval for a rare brain disorder treatment.
Read more →Friday after-hours is where retail volunteers to finance weekend carry risk.
Read more →Vale officially shelved its critical minerals IPO, and the tape greeted the scrapped spin-off with a flat +0.03% shrug into Friday's close.
Read more →UiPath ($PATH) matched second-quarter consensus EPS and beat top-line revenue, yet shares cratered 16.47% into the lunch hour.
Read more →Receipts first: yesterday's $AKAN fade call delivered, opening at 3.78 and closing at 3.67 (-3% red).
Read more →Akanda Corp ($AKAN) rallied 10.90% in after-hours trading on exactly zero fresh news.
Read more →